卒中后认知功能障碍研究新进展

doi:10.3969/j.issn.1673-5765.2017.10.018

摘要/Abstract

摘要：

卒中和痴呆的关系是目前研究的热点。卒中能够增加血管性认知障碍的发生风险，加速已经存在的认知功能障碍。卒中发生和认知障碍出现之间，有一段时间间隔，而这个时间间隔通常是实施干预治疗，预防认知障碍发生及进展的最佳时机。卒中可以同时激活神经血管单元的神经变性过程和血管损伤过程，从而加速认知障碍发生。本文主要阐述了卒中后认知功能障碍的发生率、病理生理机制、生物学标志物以及影像学特征、神经心理学评估方面的相关研究进展，为卒中后认知障碍的干预治疗提供思路。

文章导读： 卒中后认知功能障碍发生率高，脑血管病变和神经变性病变均参与卒中后认知功能障碍的发展，因此，应该对其综合治疗。

关键词: 卒中后认知障碍; 预测因子; 治疗

Abstract:

The relationship between stroke and dementia was a hot research topic area. Stroke could facilitate the onset of vascular dementia and aggravate pre-existing cognitive impairment. There was often a delay in the development of cognitive impairment after a stroke. This delay could be considered as the best therapeutic time window allowing interventions to preserve cognitive decline following stroke. Both neurodegenerative and vascular mechanisms were activated within the neurovascular unit and result in disease process. This review focused on the prevalence of cognitive impairment following stroke, physiopathologic mechanisms, biomarkers, imaging features and neuropsychological assessment, so as to provide new ideas for intervention treatments of post-stroke cognitive impairment.

Key words: Post-stroke cognitive impairment; Predictors; Treatment

左丽君，廖晓凌，李子孝，杨明，张巍，王拥军. 卒中后认知功能障碍研究新进展[J]. 中国卒中杂志, 2017, 12(10): 962-967.

ZUO Li-Jun, LIAO Xiao-Ling, LI Zi-Xiao, YANG Ming, ZHANG Wei, WANG Yong-Jun. The Research Progress of Post-stroke Cognitive Impairment[J]. Chinese Journal of Stroke, 2017, 12(10): 962-967.

参考文献

[1] PENDLEBURY S T，ROTHWELL P M. Prevalence，

incidence，and factors associated with pre-stroke and

post-stroke dementia：a systematic review and metaanalysis[

J]. Lancet Neurol，2009，8（11）：1006-1018.

[2] IHLE-HANSEN H，THOMMESSEN B，

FAGERLAND M W，et al. Blood pressure control

to prevent decline in cognition after stroke[J]. Vasc

Health Risk Manag，2015，11：311-316.

[3] VAN ROOIJ F G，KESSELS R P，RICHARD E，et

al. Cognitive impairment in transient ischemic attack

patients：a systematic review[J]. Cerebrovasc Dis，

2016，42（1-2）：1-9.

[4] 解恒革. 认知损害应成为卒中后综合管理的重点[J].

中华内科杂志，2017，56（2）：89-91.

[5] GOTTESMAN R F，HILLIS A E. Predictors and

assessment of cognitive dysfunction resulting from

ischaemic stroke[J]. Lancet Neurol，2010，9（9）：

895-905.

[6] SCHAAPSMEERDERS P，MAAIJWEE N A，VAN

DIJK E J，et al. Long-term cognitive impairment

after first-ever ischemic stroke in young adults[J].

Stroke，2013，44（6）：1621-1628.

[7] GORELICK P B，NYENHUIS D. Stroke and

cognitive decline[J]. JAMA，2015，314（1）：29-30.

[8] THIEL A，CECHETTO D F，HEISS W D，et al.

Amyloid burden，neuroinflammation，and links to

cognitive decline after ischemic stroke[J]. Stroke，

2014，45（9）：2825-2829.

[9] JELLINGER K A. Pathology and pathogenesis of

vascular cognitive impairment-a critical update[J].

Front Aging Neurosci，2013，5：17. doi：10.3389/

fnagi.2013.00017. eCollection 2013.

[10] KLIPER E，BASHAT D B，BORNSTEIN N

M，et al. Cognitive decline after stroke：relation

to inflammatory biomarkers and hippocampal

volume[J]. Stroke，2013，44（5）：1433-1435.

[11] TSENG C H，HUANG W S，MUO C H，et

al. Increased risk of dementia among chronic

osteomyelitis patients[J]. Eur J Clin Microbiol Infect

Dis，2015，34（1）：153-159.

[12] PANNESE E. Morphological changes in nerve cells

during normal aging[J]. Brain Struct Funct，2011，

216（2）：85-89.

[13] YANG J，WONG A，WANG Z，et al. Risk factors for

incident dementia after stroke and transient ischemic

attack[J]. Alzheimers Dement，2015，11（1）：16-23.

[14] MEHRABIAN S，RAYCHEVA M，PETROVA

N，et al. Neuropsychological and neuroimaging

markers in prediction of cognitive impairment after

ischemic stroke：a prospective follow-up study[J].

Neuropsychiatr Dis Treat，2015，11：2711-2719.

[15] BRESSLER S L，MENON V. Large-scale brain

networks in cognition：emerging methods and

principles[J]. Trends Cogn Sci，2010，14（6）：277-

290.

[16] LIM J S，KIM N，JANG M U，et al. Cortical hubs

and subcortical cholinergic pathways as neural

substrates of poststroke dementia[J]. Stroke，2014，45

（4）：1069-1076.

[17] LIU W，WONG A，AU L，et al. Influence of

amyloid-beta on cognitive decline after stroke/

transient ischemic attack：three-year longitudinal

study[J]. Stroke，2015，46（11）：3074-3080.

[18] DEMEYERE N，RIDDOCH M J，SLAVKOVA

E D，et al. The Oxford Cognitive Screen（OCS）：

validation of a stroke-specific short cognitive

screening tool[J]. Psychol Assess，2015，27（3）：883-894.

[19] PENDLEBURY S T，CHEN P J，BULL L，et al.Methodological factors in determining rates of

dementia in transient ischemic attack and stroke：（Ⅰ）

impact of baseline selection bias[J]. Stroke，2015，46

（3）：641-646.

[20] HARRISON J K，FEARON P，NOEL-STORR A

H，et al. Informant Questionnaire on Cognitive

Decline in the Elderly（IQCODE） for the diagnosis

of dementia within a secondary care setting[J].

Cochrane Database Syst Rev，2015，（3）：CD010772.

[21] ORGANIZATION W H. The ICD-10 classification

of mental and behavioural disorders：clinical

descriptions and diagnostic guidelines[M]. Geneva：

World Health Organization，1992.

[22] SACHDEV P，KALARIA R，O'BRIEN J，et al.

Diagnostic criteria for vascular cognitive disorders：

a VASCOG statement[J]. Alzheimer Dis Assoc

Disord，2014，28（3）：206-218.

[23] DIENER H C，SACCO R L，YUSUF S，et al.

Effects of aspirin plus extended-release dipyridamole

versus clopidogrel and telmisartan on disability and

cognitive function after recurrent stroke in patients

with ischaemic stroke in the Prevention Regimen for

Effectively Avoiding Second Strokes （PRoFESS）

trial：a double-blind，active and placebo-controlled

study[J]. Lancet Neurol，2008，7（10）：875-884.

[24] ANKOLEKAR S，GEEGANAGE C，ANDERTON

P，et al. Clinical trials for preventing post stroke

cognitive impairment[J]. J Neurol Sci，2010，299（1-

2）：168-174.

[25] XU W，QIU C，GATZ M，et al. Mid- and latelife

diabetes in relation to the risk of dementia：a

population-based twin study[J]. Diabetes，2009，58

（1）：71-77.

[26] ADVANCE COLLABORATIVE GROUP，PATEL

A，MACMAHON S，et al. Intensive blood glucose

control and vascular outcomes in patients with type

2 diabetes[J]. N Engl J Med，2008，358（24）：2560-

2572.

[27] MANKTELOW B N，POTTER J F. Interventions

in the management of serum lipids for preventing

stroke recurrence[J]. Cochrane Database Syst Rev，

2009，（3）：CD002091.

[28] MOORE S A，HALLSWORTH K，JAKOVLJEVIC

D G，et al. Effects of community exercise therapy on

metabolic，brain，physical，and cognitive function

following stroke：a randomized controlled pilot

trial[J]. Neurorehabil Neural Repair，2015，29（7）：

623-635.

[29] IHLE-HANSEN H，THOMMESSEN B，

FAGERLAND M W，et al. Effect on anxiety and

depression of a multifactorial risk factor intervention

program after stroke and TIA：a randomized

controlled trial[J]. Aging Ment Health，2014，18（5）：

540-546.

[30] JIA J，WEI C，LIANG J，et al. The effects of DL-3-

n-butylphthalide in patients with vascular cognitive

impairment without dementia caused by subcortical

ischemic small vessel disease：a multicentre，

randomized，double-blind，placebo-controlled

trial[J]. Alzheimers Dement，2016，12（2）：89-99.

[31] BLACK S，ROMÁN G C，GELDMACHER D S，et

al. Efficacy and tolerability of donepezil in vascular

dementia：positive results of a 24-week，multicenter，

international，randomized，placebo-controlled

clinical trial[J]. Stroke，2003，34（10）：2323-2330.

[32] WILKINSON D，DOODY R，HELME R，et al.

Donepezil in vascular dementia：a randomized，

placebo-controlled study[J]. Neurology，2003，61

（4）：479-486.

[33] MALOUF R，BIRKS J. Donepezil for vascular

cognitive impairment[J]. Cochrane Database Syst

Rev，2004，（1）：CD004395.

[34] HAO Z，LIU M，LIU Z，et al. Huperzine A for

vascular dementia[J]. Cochrane Database Syst Rev，

2009，（2）：CD007365.

[35] KAVIRAJAN H，SCHNEIDER L S. Efficacy and

adverse effects of cholinesterase inhibitors and

memantine in vascular dementia：a meta-analysis of

randomised controlled trials[J]. Lancet Neurol，2007，

6（9）：782-792.